Key Studies of Vaccine-Preventable Diseases Influencing My Practice Following IDWeek 2021

September 29 - October 3, 2021; Virtual
In this downloadable slideset, CCO’s expert faculty summarizes important studies from IDWeek 2021, including new data on vaccines for pneumococcal disease, respiratory syncytial virus, herpes zoster, and influenza.
Martin C. Mahoney, MD, PhD
Format: Microsoft PowerPoint (.ppt)
File Size: 3.07 MB
Released: November 3, 2021


Provided by Clinical Care Options, LLC.

Contact Clinical Care Options

For customer support please email:

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Janssen Therapeutics, Division of Janssen Products, LP
Merck Sharp & Dohme Corp.

Related Content

Expert faculty discuss guideline recommendations for nontuberculous mycobacterial lung disease (NTM-LD), from Clinical Care Options (CCO)

Keira A. Cohen, MD
Program Director
person default David E. Griffith, MD Princy N. Kumar, MD, FIDSA, MACP
Physicians: maximum of 1.0 AMA PRA Category 1 Credit Pharmacists: 1.0 contact hour (0.1 CEUs) Released: November 19, 2021 Expired: November 18, 2022

Clinical Care Options (CCO): Dr. Paul Auwaerter discusses the latest pneumococcal vaccine data and the impact on his practice, presented at IDWeek 2021

Paul G. Auwaerter, MD Released: November 19, 2021

Expert IDWeek 2021 video: vaccines for pneumococcal disease, respiratory syncytial virus, herpes zoster, and influenza, from CCO

Martin C. Mahoney, MD, PhD Released: November 11, 2021

Download key slides on guidance and CDC recommendations on vaccination to prevent shingles and its complications in the COVID-19 era.

person default Dalilah Restrepo, MD Released: November 10, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.